SRA Completes Acquisition of Constella Group
August 09 2007 - 5:01PM
PR Newswire (US)
FAIRFAX, Va., Aug. 9 /PRNewswire-FirstCall/ -- SRA International,
Inc. (NYSE:SRX), a leading provider of technology and strategic
consulting services and solutions to federal government
organizations, announced that it has completed the acquisition of
Constella Group, LLC, a privately-held global provider of health
consulting services, effective today. Headquartered in Durham, NC,
Constella delivers professional services to customers around the
world. Through its work in health sciences, international
development and product development, Constella collaborates with
experts in local and national governments, academia,
non-governmental organizations and pharmaceutical and biotechnology
companies to support a broad range of health missions. Constella's
reported revenue for calendar year 2006 was approximately $169
million, including partial-year results for the two companies it
acquired during the year. SRA President and CEO Stan Sloane said,
"We're very pleased to welcome Constella's employees and customers
into SRA. The global health market represents a growing area of
demand for professional solutions and is a key focus of our
long-term strategy. We're enthusiastic about the potential of the
SRA-Constella team to address complex health issues across the
globe." About SRA International, Inc. SRA is a leading provider of
technology and strategic consulting services and solutions -
including systems design, development, and integration; and
outsourcing and managed services - to clients in national security,
civil government, and health care and public health markets. The
Company also delivers business solutions for contingency and
disaster response planning, information assurance, business
intelligence, environmental strategies, enterprise architecture,
infrastructure management, and wireless integration. FORTUNE(R)
magazine has chosen SRA as one of the "100 Best Companies to Work
For" for eight consecutive years. The Company's 6,300 employees
serve clients from its headquarters in Fairfax, Virginia, and
offices across the country. For additional information on SRA,
please visit http://www.sra.com/. Any statements in this press
release about future expectations, plans, and prospects for SRA,
including statements containing the words "estimates," "believes,"
"anticipates," "plans," "expects," "will," and similar expressions
constitute forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including:
risks concerning the future financial performance of the acquired
company, our dependence on our contracts with federal government
agencies, particularly within the U.S. Department of Defense, for
substantially all of our revenue, our dependence on our GSA
schedule contracts and our position as a prime contractor on
government-wide acquisition contracts and other multiple-award
contracts to grow our business, and other factors discussed in our
latest quarterly report on Form 10-Q filed with the Securities and
Exchange Commission on May 3, 2007. In addition, the
forward-looking statements included in this press release represent
our views as of August 9, 2007. We anticipate that subsequent
events and developments will cause our views to change. However,
while we may elect to update these forward-looking statements at
some point in the future, we specifically disclaim any obligation
to do so. These forward-looking statements should not be relied
upon as representing our views as of any date subsequent to August
9, 2007. DATASOURCE: SRA International, Inc. CONTACT: David Keffer,
Director, Investor Relations, +1-703-502-7731, , or Stephen Hughes,
Executive VP and CFO, +1-703-502-7732, , both of SRA International,
Inc. Web site: http://www.sra.com/
Copyright
Sra (NYSE:SRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sra (NYSE:SRX)
Historical Stock Chart
From Jul 2023 to Jul 2024